⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 1, 2004Expert Review of Pharmacoeconomics & Outcomes ResearchOpen Access

Using pharmacoeconomics for policy making: is rational decision making enhanced by applying thresholds for cost-effectiveness?

Jasper M Bos Maarten J. Postma

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

making enhanced by applying thresholds for costeffectiveness?, Expert

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bos et al. (2004) studied this question.

synapsesocial.com/papers/6acc7279c8ee16ac261233fc https://doi.org/10.1586/14737167.4.3.247

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Inconsistencies in the "Societal Perspective" on Costs of the Panel on Cost-Effectiveness in Health and MedicineCost-Effectiveness Analysis · 1999 · 94 citations
2Discounting for health effects in cost–benefit and cost‐effectiveness analysisCost-Effectiveness Analysis · 2001 · 177 citations
3Fieller's method and net health benefitsCost-Effectiveness Analysis · 2000 · 65 citations
4Statistical determination of cost‐effectiveness frontier based on net health benefitsCost-Effectiveness Analysis · 2002 · 12 citations
5Pharmaco‐economics of blood transfusion safety: review of the available evidenceCost-Effectiveness Analysis · 2002 · 66 citations

Valuing the effects of sildenafil in erectile dysfunction2000
Expert review of pharmacoeconomics and outcomes Research: high impact articles from 2025Expert Review of Pharmacoeconomics & Outcomes Research · 2026
Cost-utility of expanded hypertension screening and treatment among adults covered by Peru’s Seguro integral de salud: a markov Model using national dataExpert Review of Pharmacoeconomics & Outcomes Research · 2026
Machine learning in comparative effective research of pharmacological interventions: a scoping reviewExpert Review of Pharmacoeconomics & Outcomes Research · 2026
The presence of prior-effects of the Medicaid expansion on Drug prescriptionExpert Review of Pharmacoeconomics & Outcomes Research · 2026

More from Expert Review of Pharmacoeconomics & Outcomes Research

More from University of Groningen